Advertisement

Topics

Flamel Technologies, S.A. Company Profile

20:26 EDT 25th September 2017 | BioPortfolio

Flamel Technologies, S.A. is a biopharmaceutical company principally engaged in the development of two unique polymer-based delivery technologies for medical applications. Flamel's Medusa technology is designed to deliver controlled-release formulations of therapeutic proteins and peptides and other molecules, without reduction in bioactivity. Micropump® is a controlled release and taste-masking technology for the oral administration of small molecule drugs; it is the intellectual platform licensed by GlaxoSmithKline for COREG CR® (carvedilol phosphate).


News Articles [427 Associated News Articles listed on BioPortfolio]

Reviewing Flamel Technologies

Flamel Technologies and Acura Pharmaceuticals are both small-cap medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their profitabiliy,...

Acura Pharmaceuticals (ACUR) vs. Flamel Technologies (AVDL) Financial Analysis

Flamel Technologies and Acura Pharmaceuticals are both small-cap medical companies, but which is the better business? We will contrast the two companies based on the strength of their earnings, instit...

Head to Head Survey: Flamel Technologies

Flamel Technologies and Acura Pharmaceuticals are both small-cap medical companies, but which is the superior stock? We will compare the two companies based on the strength of their risk, institutiona...

Comparing Acura Pharmaceuticals

Acura Pharmaceuticals and Flamel Technologies are both small-cap medical companies, but which is the better business? We will contrast the two businesses based on the strength of their risk, valuation...

Advanced Enzymes acquires evoxx

The industrial biotechnology company evoxx technologies GmbH has become a part of specialty biotech company Advanced Enzyme Technologies Limited. Both companies announced that they have entered into a...

Partnership agreement signed to combine epigenetics technologies

A partnership agreement has been entered into by Cambridge Epigenetix (CEGX) and NuGEN Technologies to cover the manufacture and integration of technologies for epigenetic research.

Agilent acquires Cobalt, expanding value for pharma and biopharma

Specialist in analytical laboratory technologies, Agilent Technologies, has acquired Cobalt Light Systems, which develops products and technologies for non-invasive, through-barrier chemical analysis ...

DBV Technologies: DBV Technologies Announces Appointment of Julie O'Neill to Board of Directors

Press Release Montrouge, France, June 15, 2017 DBV Technologies Announces Appointment of Julie O'Neill to Board of Directors DBV Technologies (Euronext: DBV - ISIN: FR0010417345 - Nasdaq Stock Mar...

PubMed Articles [411 Associated PubMed Articles listed on BioPortfolio]

Advanced technologies for the remediation of pesticide-contaminated soils.

The occurrence of pesticides in soil has become a highly significant environmental problem, which has been increased by the vast use of pesticides worldwide and the absence of remediation technologies...

Enhancing the Gaming Experience Using 3D Spatial User Interface Technologies.

Three-dimensional (3D) spatial user interface technologies have the potential to make games more immersive and engaging and thus provide a better user experience. Although technologies such as stereos...

Technologies to Support Community-Dwelling Persons With Dementia: A Position Paper on Issues Regarding Development, Usability, Effectiveness and Cost-Effectiveness, Deployment, and Ethics.

With the expected increase in the numbers of persons with dementia, providing timely, adequate, and affordable care and support is challenging. Assistive and health technologies may be a valuable cont...

3D Metal Printing - Additive Manufacturing Technologies for Frameworks of Implant-Borne Fixed Dental Prosthesis.

An edentulous patient was rehabilitated with maxillary metal-ceramic and mandibular metal-resin implant-supported fixed dental prosthesis (FDP). Metal frameworks of the FDPs were fabricated using 3D a...

Amyloid Beta and Tau as Alzheimer's Disease Blood Biomarkers: Promise From New Technologies.

The utility of the levels of amyloid beta (Aβ) peptide and tau in blood for diagnosis, drug development, and assessment of clinical trials for Alzheimer's disease (AD) has not been established. The l...

Clinical Trials [308 Associated Clinical Trials listed on BioPortfolio]

Application of Monitoring and Intervention Technologies in Suboptimal Health Status

The purpose of this study is to use monitoring and intervention technologies in suboptimal health status in a general population in China and evaluate the effectiveness of these technologi...

Wheeze Detection in Adults During Dynamic Bronchial Situations Measured by PulmoTrack® 2010 With WIM-PC™ Technologies Recording

The PulmoTrack® 2010 with WIM-PC™ Technologies device, indicated for acoustic pulmonary function measurement that quantifies the presence of wheezing. This study was designed in order t...

Objective Functional Outcome Measures in Orthopedic Surgery Using Advanced Tracking Technologies

The proposed project will address the measurement and ramifications of out-of-home mobility problems in various orthopedic disorders in an innovative way, using advanced tracking technolog...

Online Peer Networked Collaborative Learning for Managing Depressive Symptoms

The mission of this project is to develop novel systems of care that can provide efficacious, scalable, cost-effective, participant friendly technology assisted behavioral interventions (T...

Longitudinal Study of Chronic Wounds Using Novel Wound Measurement Technologies

An open, non-randomised longitudinal study of diabetic foot ulcers receiving standardised treatment, over a 16 week period conducted at out-patient level, utilising novel optical wound mea...

Companies [1220 Associated Companies listed on BioPortfolio]

Flamel Technologies

Flamel Technologies is a drug delivery company with expertise in polymer chemistry. The company was founded in 1990. In 1996, Flamel Technologies (FLML) became the second French biotech company to e...

Flamel Technologies, S.A.

Flamel Technologies, S.A. is a biopharmaceutical company principally engaged in the development of two unique polymer-based delivery technologies for medical applications. Flamel'...

Flamel Technologies SA and Digna Biotech SL

Flamel Technologies SA (NASDAQ: FLML) is a leading drug delivery company focused on the goal of developing safer, more efficacious formulations of drugs that address unmet medical...

Flamel Technologies S.A.

Flamel Technologies is a drug delivery company with two intellectual property platforms: Micropump, for the controlled release of drugs best absorbed in the small intestine; and M...

LVL Technologies, Inc.

LVL Technologies, Inc. was founded by Dr. Dustin Freckleton and Nithin Rajan with a mission of bringing the accuracy of medical device technologies to the consumer wearables marke...

More Information about "Flamel Technologies, S.A." on BioPortfolio

We have published hundreds of Flamel Technologies, S.A. news stories on BioPortfolio along with dozens of Flamel Technologies, S.A. Clinical Trials and PubMed Articles about Flamel Technologies, S.A. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Flamel Technologies, S.A. Companies in our database. You can also find out about relevant Flamel Technologies, S.A. Drugs and Medications on this site too.

Quick Search
Advertisement
 

Relevant Topic

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...


Corporate Database Quicklinks



Searches Linking to this Company Record